Login

Kuvera co-founder Neelabh Sanyal invests 80% of his portfolio in equities through index funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Pack Expo Insights: Sluggish Volumes and M&A Trends in the Packaging Industry
00:10:00
Venture capital firm on a mission to diversify the face of wealth|Diana Murakhovskaya,Co-Founder and General Partner,The Artemis Fund
00:10:00
Interview with the biggest energy sector based comapny Abraj Energy Service | Saif Al Hamhami, CEO, Abraj Energy Services SAOGABRJ:MUS
00:10:00
Get River Diamonds Limited: Developing the Blina Alluvial Diamond Project in Western Australia
00:10:00
New Year's Financial Resolutions: Tips for a Secure and Successful Year
00:10:00
Celebrating Innovation: Seeking the Most Innovative SME with CHF 17,000 in Prize Money | Johann Reiter, CEO, Vetropack Holding AG.
00:10:00
The Nuances of Commercial Real Estate: Insights from an Industry Leader | Michelle M. MacKay, CEO,Cushman & Wakefield PLC.
00:10:00
AdvTech Sees Continued Enrollment Growth Across Africa Amid High Demand for Quality Education | Roy Douglas, CEO, Advtech Ltd .
00:10:00
Interview with Award Winner on Challenges in M&A and Finance
00:10:00
Experts in Consumer Products, Apparel, Retail and related Technology & Digital Markets|Richard,co-founder,Triangle Capital LLC
00:10:00
"Navigating Compliance with the SEC’s Climate Disclosure Rule: Comprehensive Strategies for Accurate and Transparent Reporting"
00:10:00
Wojciech Kowalczyk, CEO of Boryszew SA, discusses the company's very strong financial results for 2022 and the implementation of a new strategy.|Wojciech Kowalczyk, CEO of Boryszew SA,

© 2017 - Neuhu+